结构蛋白域在无细胞反应环境中的糖化
Erik J Bidstrup1, Kyle Hill2, Chandra K Bandi1
1Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, United States.
ACS synthetic biology
|May 28, 2025
概括
无细胞的细菌系统可以产生复杂的葡萄糖蛋白,即使在结构化的区域. 这项研究揭示了无细胞提取物中一种新的协同翻译型糖化机制,使得治疗性糖蛋白的高效生产成为可能.
科学领域:
- 生物技术和生物制造
- 分子生物学分子生物学
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 细菌N链蛋白质糖化系统通常使用单个亚单元的寡糖糖转移酶 (OST),有利于灵活的受体位点.
- 虽然结构域的糖化在体内发生,但在无细胞系统中的机制尚不清楚.
- 无细胞糖蛋白合成 (CFGpS) 提供了低成本生物制造的潜力.
研究的目的:
- 研究以大肠杆菌为基础的CFGpS系统中结构域的N链 glycosylation 的机制.
- 为了确定是否可以在真核糖蛋白的结构上受限制的区域中发生无细胞糖化.
主要方法:
- 使用基于大肠杆菌的无细胞糖蛋白合成 (CFGpS) 系统.
- 评估了真核糖蛋白 (RNase A,IgG Fc片段) 的糖化效率,其受体位点位于受限区域.
- 研究依赖于核糖体翻译和信号介导的转位.
主要成果:
- 在CFGpS系统中观察到RNase A和IgG Fc片段的高效糖化,即使在受限区域的受体位点中也是如此.
- 对于以前未被折叠的蛋白质,发生了糖化,这表明与体内过程不同的机制.
- 无细胞糖化依赖于核糖体翻译,但独立于信号介导转位.
结论:
- 为CFGpS系统提出了一个独特的协同翻译,但不是协同翻译的糖化机制.
- CFGpS显示出作为生产复杂真核糖蛋白,包括治疗点的可行平台的潜力.
- 这些发现有助于更好地了解细菌糖化机制,并扩大生物制造的可能性.
相关概念视频
Protein Glycosylation
7.3K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
7.3K
Oligosaccharide Assembly
3.0K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.0K
Protein Folding Quality Check in the RER
3.9K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.9K
Proteoglycans
4.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
Protein Modifications in the RER
5.7K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.7K
Protein Folding
121.9K
Overview
121.9K


